Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorZacharova, Marija
dc.contributor.authorTulloch, Lindsay
dc.contributor.authorGould, Eoin
dc.contributor.authorFraser, Andrew
dc.contributor.authorKing, Elizabeth
dc.contributor.authorMenzies, Stefanie
dc.contributor.authorSmith, Terry K.
dc.contributor.authorFlorence, Gordon J.
dc.date.accessioned2019-06-07T10:30:06Z
dc.date.available2019-06-07T10:30:06Z
dc.date.issued2019-09-01
dc.identifier258881377
dc.identifier1138045f-77f8-445a-8aff-85515697f7a7
dc.identifier85066630767
dc.identifier000483709700047
dc.identifier.citationZacharova , M , Tulloch , L , Gould , E , Fraser , A , King , E , Menzies , S , Smith , T K & Florence , G J 2019 , ' Structure‐based design, synthesis and biological evaluation of bis‐tetrahydropyran furan acetogenin mimics targeting the trypanosomatid F1 component of ATP synthase ' , European Journal of Organic Chemistry , vol. 2019 , no. 31-32 , pp. 5434-5440 . https://doi.org/10.1002/ejoc.201900541en
dc.identifier.issn1434-193X
dc.identifier.otherORCID: /0000-0001-9921-4399/work/58055412
dc.identifier.otherORCID: /0000-0002-8987-5561/work/58055474
dc.identifier.otherORCID: /0000-0001-7223-5106/work/58055789
dc.identifier.urihttps://hdl.handle.net/10023/17843
dc.descriptionThis work was funded by the Leverhulme Trust (G.J.F.), Wellcome Trust ISSF support (G.J.F./T.K.S.) and the European Community’s Seventh Framework Programme under grant agreement No. 602773 [Project KINDRED] (T.K.S.).en
dc.description.abstractThe protozoan parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are responsible for the severely debilitating neglected Tropical diseases of African sleeping sickness, Chagas disease and leishmaniasis, respectively. As part of our ongoing programme exploring the potential of simplified analogues of the acetogenin chamuvarinin we identified the T. brucei FoF1‐ATP synthase as a target of our earlier triazole analogue series. Using computational docking studies we hypothesized that the central triazole heterocyclic spacer could be substituted for a central 2,5‐substituted furan moiety, thus diversifying the chemical framework for the generation of compounds with greater potency and/or selectivity. Here we report the design, docking, synthesis and biological evaluation of new series of trypanocidal compounds and demonstrate their on‐target inhibitory effects. Furthermore, the synthesis of furans by the modular coupling of alkyne‐ and aldehyde‐THPs to bis‐THP 1,4‐alkyne diols followed by ruthenium/xantphos‐catalysed heterocyclisation described here represents the most complex use of this method of heterocyclisation to date.
dc.format.extent8
dc.format.extent4343760
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Organic Chemistryen
dc.subjectTrypanosomatiden
dc.subjectNeglected tropical diseaseen
dc.subjectDrug designen
dc.subjectFoF1-ATP synthaseen
dc.subjectRuthenium/xantphos-catalysed heterocyclisationen
dc.subjectQD Chemistryen
dc.subjectNDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccQDen
dc.titleStructure‐based design, synthesis and biological evaluation of bis‐tetrahydropyran furan acetogenin mimics targeting the trypanosomatid F1 component of ATP synthaseen
dc.typeJournal articleen
dc.contributor.sponsorThe Wellcome Trusten
dc.contributor.sponsorThe Leverhulme Trusten
dc.contributor.sponsorEuropean Commissionen
dc.contributor.institutionUniversity of St Andrews. School of Chemistryen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews. School of Biologyen
dc.contributor.institutionUniversity of St Andrews. EaSTCHEMen
dc.identifier.doi10.1002/ejoc.201900541
dc.description.statusPeer revieweden
dc.identifier.grantnumberen
dc.identifier.grantnumberRL-2012-025en
dc.identifier.grantnumber602773en


This item appears in the following Collection(s)

Show simple item record